Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases VAT and Sales Tax VAT and Sales Tax + HC VAT and Sales Tax - 2017 (1) TMI HC This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2017 (1) TMI 1465 - HC - VAT and Sales Tax


Issues Involved:
1. Taxability of "Shower to Shower" and "Listerine Mouthwash" under RVAT Act.
2. Classification of "Savlon" as a drug or medicine.
3. Imposition of penalty under Section 61 of the RVAT Act.

Detailed Analysis:

1. Taxability of "Shower to Shower" and "Listerine Mouthwash":

The primary issue was whether "Shower to Shower" and "Listerine Mouthwash" should be classified under Entry 43 of "Drugs and Medicines" in Schedule-IV of the RVAT Act, or under the residuary entry in Schedule-V, attracting a higher tax rate of 12.5%. The Assessing Officer (AO) and Dy. Commissioner (Appeals) concluded that these products do not qualify as drugs or medicines, applying the test of common parlance. The Tax Board upheld this view, noting that these products are freely available in the market, are used for general purposes like feeling fresh or removing body odor, and contain only minor percentages of medicinal ingredients. The court agreed with this assessment, stating that these products are essentially cosmetics and do not meet the criteria to be classified as drugs or medicines under the RVAT Act. The court emphasized that even if these products have some medicinal properties, they are primarily used as cosmetics and are not prescribed by doctors or sold exclusively by licensed traders.

2. Classification of "Savlon" as a Drug or Medicine:

The Revenue challenged the Tax Board's classification of "Savlon" as a drug, arguing it should be taxed at a higher rate. The Tax Board had previously held that "Savlon" has medicinal value, similar to "Dettol," and should be taxed at a lower rate applicable to drugs and medicines. The court upheld the Tax Board's decision, noting that "Savlon" is used as an antiseptic for cuts, abrasions, and minor burns, serving a curative purpose. The court referenced the Supreme Court's decision in Commissioner of Central Excise v. Sharma Chemical Works, which held that products used for treating ailments and containing curative ingredients should be classified as medicaments. The court also cited the Kerala High Court's decision in Reckitt Benckiser (India) Ltd. v. State of Kerala, which classified "Dettol" as a disinfectant with antiseptic properties, supporting the view that "Savlon" falls within the ambit of drugs and medicines.

3. Imposition of Penalty under Section 61 of the RVAT Act:

The Revenue appealed against the Tax Board's deletion of the penalty imposed under Section 61 of the RVAT Act. The AO had levied the penalty, claiming the assessee concealed particulars and furnished inaccurate details by paying a lower tax rate. The court, however, agreed with the Tax Board's decision to delete the penalty, noting that the issue was one of classification, making it debatable. The court emphasized that penalties are not justified in cases where the classification of goods is disputed and all relevant entries are recorded in the books of account. The court referenced the Supreme Court's decision in Sree Krishna Electricals v. State of Tamil Nadu, which held that penalties cannot be imposed when items not included in the turnover are disclosed in the dealer's account books and subsequently included by the assessing authority. The court also cited its own decision in CTO v. Bambino Agro Industries Ltd., which supported the view that penalties are not applicable in cases of bona fide classification errors.

Conclusion:

The court dismissed the petitions filed by both the assessee and the Revenue. It upheld the Tax Board's classification of "Shower to Shower" and "Listerine Mouthwash" as non-medicinal products taxable at the higher residuary rate, and "Savlon" as a drug taxable at a lower rate. The court also upheld the Tax Board's decision to delete the penalty imposed under Section 61, finding no concealment or furnishing of inaccurate particulars by the assessee.

 

 

 

 

Quick Updates:Latest Updates